Dr. Clemens described the projects that the network has undertaken since 2012, including a longitudinal cohort study with a goal enrollment of 500 men and 500 women, with the collection of clinical information, patient-reported outcome measures, and biosamples. He outlined the goals of subtyping those with lower urinary tract symptoms, but also provided valuable insight into normal and abnormal lower urinary tract functions.
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
Presented by: Quentin Clemens University of Michigan Medical Center
at 2017 SUFU - Society of Urodynamics, Female Pelvic Medicine, February 28 – March 2, 2017 Scottsdale, Arizona, USA